SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019341
Filing Date
2022-07-14
Accepted
2022-07-14 17:09:49
Documents
15
Period of Report
2022-07-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 67534
2 ex3-1.htm EX-3.1 17125
3 ex10-1.htm EX-10.1 17036
4 ex99-1.htm EX-99.1 15397
  Complete submission text file 0001493152-22-019341.txt   305697

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20220714.xsd EX-101.SCH 2956
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20220714_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20220714_pre.xml EX-101.PRE 22357
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3735
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 221083587
SIC: 2834 Pharmaceutical Preparations